These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30259578)

  • 1. Elevation of serum oxLDL/β2-GPI complexes was correlated with diabetic microvascular complications in Type 2 diabetes mellitus patients.
    Xie L; Lin H; Wang C
    J Clin Lab Anal; 2019 Feb; 33(2):e22676. PubMed ID: 30259578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Levels of Serum β2-Glycoprotein I/Oxidized Low-Density Lipoprotein Complexes Are Associated with Cerebral Infarction in Patients with Type 2 Diabetes Mellitus.
    Zhang L; Wu Y; Qiu L; Liu Y; Li Q
    Med Sci Monit; 2018 Feb; 24():1232-1240. PubMed ID: 29489742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
    Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
    J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum β2-glycoprotein-I-lipoprotein(a) complexes levels are associated with the presence and complications in type 2 diabetes mellitus.
    Wang C; Niu DM; Hu J; Guan XC; Yang W; Wang JJ; Zhang CY; Zhang CN
    Diabetes Res Clin Pract; 2013 May; 100(2):250-6. PubMed ID: 23549246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
    Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
    J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Serum β2-GPI/oxLDL and the Risk of Cerebral Infarction in Patients with T2DM.
    Kuang W; Li Y; Liu G; Zhang Y; Chen G; Luo B; Kuang S
    Front Surg; 2022; 9():930701. PubMed ID: 35898588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
    Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
    J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
    Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
    Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between serum 1, 5-anhydroglucitol level and insulin resistance, microvascular complications in type 2 diabetes mellitus].
    Tan AC; Zhang Q; Cheng J; Yan XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jun; 58(6):875-882. PubMed ID: 38955736
    [No Abstract]   [Full Text] [Related]  

  • 12. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
    Berger JS; Rockman CB; Guyer KE; Lopez LR
    J Immunol Res; 2014; 2014():234316. PubMed ID: 25405208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidized low-density lipoprotein/β2-glycoprotein I complex is associated with abdominal obesity in healthy middle-aged men.
    Kraml PJ; Syrovátka P; Potočková J; Anděl M
    Ann Nutr Metab; 2013; 62(1):7-13. PubMed ID: 23171597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoprotein(a) complexes with beta2-glycoprotein I levels in patients with ischemic stroke.
    Ma L; Wu J; Niu D; Yu R; Song J; Zhang C; Wang J
    Clin Chim Acta; 2014 Feb; 429():163-7. PubMed ID: 24315780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum oxidized low-density lipoprotein/beta2-glycoprotein I complexes in patients with chronic renal diseases.
    Kasahara J; Kobayashi K; Maeshima Y; Yamasaki Y; Yasuda T; Matsuura E; Makino H
    Nephron Clin Pract; 2004; 98(1):c15-24. PubMed ID: 15361700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum oxLDL-β2GPI complex reflects metabolic syndrome and inflammation in adipose tissue in obese.
    Siklova M; Koc M; Rossmeislová L; Kraml P
    Int J Obes (Lond); 2018 Mar; 42(3):405-411. PubMed ID: 29081508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
    Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.